核酸不对称性和灵活的链接器动态调节P-糖蛋白的药物流出周期,一个计算研究
Sungho B Han1,2, Jim Warwicker1, Hao Fan2
1School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Rd, Manchester M13 9PL, United Kingdom.
Computational and structural biotechnology journal
|November 24, 2025
概括
通过P-glycoprotein (P-gp) 的多药性耐药性 (MDR) 阻碍了化疗. 模拟显示了P-gpp的情况.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由P-糖蛋白 (P-gp/ABCB1) 介导的多药性耐药性 (MDR) 是癌症化疗中的一个重大挑战.
- P-gp是一种ATP结合的磁带载体,通过不太了解的核酸驱动机制排出化疗药物.
研究的目的:
- 通过模拟其核酸依赖的构造变化,阐明P-gp基质运输的机械细节.
- 调查P-gp转位周期中的动态功能洞察力.
主要方法:
- 在脂质双层中P-gp的高通量多复制分子动力学模拟 (总计约110μs).
- 适应性采样策略,以捕捉整个运输周期的核酸依赖性构造变化.
主要成果:
- 在核酸结合位点 (NBS) 的不对称核酸协调与基质流出的跨膜域 (TMD) 重组相关.
- 一个灵活的链接器形成了短暂的α螺旋,影响核酸结合域 (NBD) 分解.
- 确定了依赖于形状的基质路径和核酸特定的接入路径.
结论:
- 核酸占用率,链接器动力学和蛋白质构成的相互作用决定了P-gp的结构可塑性和基质乱交.
- 这项研究将静态结构数据与对P-gp基质转位周期的动态功能洞察结合起来.
更多相关视频
相关概念视频
Nonlinear Pharmacokinetics: Role of Transporters
262
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
262
Carrier-Mediated Transport
1.0K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.0K
Protein-Drug Binding: Mechanism and Kinetics
1.6K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.6K
Pore Transport and Ion-Pair Transport
1.1K
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
1.1K
Membrane Asymmetry Regulating Transporters
6.9K
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
6.9K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
254
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
254


